Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias M Weber

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Endocrinology|March 18, 2003
Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3Christoph J Auernhammer, Nicola B Isele, Florian B Kopp, et al.
Diabetes, Obesity & Metabolism|December 24, 2016
Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic studyThomas Forst, Alexander Falk, Grit Andersen, et al.
BMC Endocrine Disorders|February 14, 2018
Design of the Growth hormone deficiency and Efficacy of Treatment (GET) score and non-interventional proof of concept studyPeter H Kann, Simona Bergmann, Martin Bidlingmaier, et al.
Journal of Neurosurgery|January 2, 2016
Binostril versus mononostril approaches in endoscopic transsphenoidal pituitary surgery: clinical evaluation and cadaver studyJens Conrad, Ali Ayyad, Christian Wüster, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 22, 2021
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaAnja Rinke, Christoph Maintz, Lothar Müller, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 24, 2007
MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarismAnca Zimmermann, Jens-Peter Schenk, Paula Grigorescu Sido, et al.
The Journal of Endocrinology|March 12, 2004
The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cellsChristoph J Auernhammer, Franziska Dorn, George Vlotides, et al.
Pituitary|March 12, 2021
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) ProgramBeverly M K Biller, Charlotte Höybye, Paul Carroll, et al.
MMW Fortschritte Der Medizin|December 13, 2019
[Hypoparathyroidism - un underestimated problem?]Stephan Petersenn, Jörg Bojunga, Georg Brabant, et al.
Journal of the Endocrine Society|May 17, 2023
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWERBeverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Endocrinology|March 18, 2003
Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3Christoph J Auernhammer, Nicola B Isele, Florian B Kopp, et al.
Diabetes, Obesity & Metabolism|December 24, 2016
Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic studyThomas Forst, Alexander Falk, Grit Andersen, et al.
BMC Endocrine Disorders|February 14, 2018
Design of the Growth hormone deficiency and Efficacy of Treatment (GET) score and non-interventional proof of concept studyPeter H Kann, Simona Bergmann, Martin Bidlingmaier, et al.
Journal of Neurosurgery|January 2, 2016
Binostril versus mononostril approaches in endoscopic transsphenoidal pituitary surgery: clinical evaluation and cadaver studyJens Conrad, Ali Ayyad, Christian Wüster, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 22, 2021
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaAnja Rinke, Christoph Maintz, Lothar Müller, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 24, 2007
MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarismAnca Zimmermann, Jens-Peter Schenk, Paula Grigorescu Sido, et al.
The Journal of Endocrinology|March 12, 2004
The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cellsChristoph J Auernhammer, Franziska Dorn, George Vlotides, et al.
Pituitary|March 12, 2021
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) ProgramBeverly M K Biller, Charlotte Höybye, Paul Carroll, et al.
MMW Fortschritte Der Medizin|December 13, 2019
[Hypoparathyroidism - un underestimated problem?]Stephan Petersenn, Jörg Bojunga, Georg Brabant, et al.
Journal of the Endocrine Society|May 17, 2023
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWERBeverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, et al.
Pageof 11